G1 Therapeutics, Inc.

CIK 1560241 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for G1 Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 13, 2024SC 13G/A0000935836-24-000655
Sep 30, 202415-12G0001193125-24-228437
Sep 18, 202440000950170-24-107790
Sep 18, 2024S-8 POS0001193125-24-221395
Sep 18, 202440000950170-24-107797
Sep 18, 2024S-8 POS0001193125-24-221379
Sep 18, 202440000950170-24-107794
Sep 18, 202425-NSE0001354457-24-000689
Sep 18, 2024S-8 POS0001193125-24-221383
Sep 18, 2024S-8 POS0001193125-24-221398
Sep 18, 202440000950170-24-107788
Sep 18, 2024SC TO-T/A0001193125-24-221103
Sep 18, 202440000950170-24-107795
Sep 18, 2024S-8 POS0001193125-24-221386
Sep 18, 2024SC 14D9/A0001193125-24-221112
Sep 18, 202440000950170-24-107799
Sep 18, 20248-K0001193125-24-221120
Sep 18, 202440000950170-24-107791
Sep 18, 202440000950170-24-107798
Sep 18, 2024S-8 POS0001193125-24-221371
Sep 18, 202440000950170-24-107787
Sep 18, 202440000950170-24-107796
Sep 18, 202440000950170-24-107800
Sep 18, 2024S-8 POS0001193125-24-221392
Sep 18, 202440000950170-24-107793